Would the Bass and Spangenberg ‘invest and invalidate’ strategy work with Chinese patents?
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
@IAM_Alerts The Supply Chain: once it was industry jargon, but this holiday season, it is a mainstream conversation topic. IAM'… https://t.co/8j2o6TpKzw Read more
@IAM_Alerts Inside the patent portfolio Ericsson gets as part of its $6 billion Vonage acquisition https://t.co/A2CIUuxfZf https://t.co/izXEIFkItt Read more
@IAM_Alerts Happy Thanksgiving to all our friends in the US (though you really shouldn’t be reading this 😉) https://t.co/TFrw9HFG8V Read more
@IAM_Alerts Pfizer acts quickly to tackle alleged covid-19 vaccine trade secrets misappropriation: https://t.co/QJntHBAm2W https://t.co/fUg5ttbuqQ Read more